The Recent Clinical Trends Of The Drugs Developed By Nanotechnology

Abstract

In view of scenario pharmaceutical industries are focusing towards their research on nanotechnology because developing new chemical entity is very time consuming and expensive affair and most of drugs will be off patent very soon causing huge revenue loss. Applications of nanotechnology to pharmacy that provide intelligent and smart drug delivery systems is expected to emerge as most important and powerful tool as alternate to conventional dosage form. These nano-intelligent drug delivery systems need little investment while expected to be a high profit making deal due to new patent-protection for current or soon-to-be off-patent drugs. Therefore most of industrial research interest lies in fact to exploit the newer technology to develop drug delivery system of available drugs in order to reduce or overcome their shortcoming like high toxicity, instability in biological environment, poor bioavailability, and low therapeutic concentration at site of action, which rendered them poor candidates in currently available dosage forms.